Your browser doesn't support javascript.
loading
Genetic markers of chronic lymphocytic leukemia: a retrospective study of 312 patients from a reference center in Lebanon.
Ayoub, Georges; Sinan, Hassan; Kourie, Hampig Raphael; Kattan, Joseph; Nasr, Fadi; Karak, Fadi El; Wakim, Jad; Ghosn, Marwan; Chahine, Georges; Farra, Chantal; Chebly, Alain.
Afiliação
  • Ayoub G; Faculty of Medicine, Saint Joseph University of Beirut, Lebanon.
  • Sinan H; Faculty of Medicine, American University of Beirut, Lebanon.
  • Kourie HR; Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon.
  • Kattan J; Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon.
  • Nasr F; Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon.
  • Karak FE; Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon.
  • Wakim J; Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon.
  • Ghosn M; Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon.
  • Chahine G; Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon.
  • Farra C; Medical Genetics Unit, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon, till march 2022.
  • Chebly A; Jacques Loiselet Center for Medical Genetics & Genomics (CGGM), Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Future Oncol ; 19(29): 1991-2002, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37795707
ABSTRACT

Aim:

Chronic lymphocytic leukemia (CLL) is a highly heterogenous hemopathy. Genetic stratification of CLL patients has important prognostic and therapeutic values - mainly immunoglobulin heavy chain variable region gene (IGHV) mutational status and the presence of cytogenetic abnormalities. The genetics of CLL in Lebanon is scarcely described in the literature. Patients &

methods:

In this work, we studied the genetic biomarkers of 312 Lebanese CLL patients.

Results:

Prominent IGHV genes were IGHV4-34, IGHV1-69 and IGHV3-30; and CLL #1 and #5 presented major subsets. Some similarities as well as major differences were highlighted when comparing our data with previously published data.

Conclusion:

The distribution of IGHV alleles in our series differed from previously described distributions, suggesting involvement of antigenic selection and regional variables in CLL pathogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Future Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Líbano

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Future Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Líbano